Skip to main content

Cervical Spinal Cord Injury clinical trials at UC Health
1 in progress, 0 open to new patients

  • Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the safety of cross sequential escalating doses of AST-OPC1 administered among 5 cohorts at a single time-point between 21 and 42 days post injury, inclusively, to subjects with subacute cervical spinal cord injuries (SCI).

    at UCSD

Last updated: